Literature DB >> 18398324

Pleiotropic effects of telmisartan: still more to come?

Ralf A Benndorf, Rainer H Böger.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18398324     DOI: 10.1097/HJH.0b013e3282f76481

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  3 in total

1.  Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonists.

Authors:  Kenneth K W To; Brian Tomlinson
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

2.  Sensitivity Enhanced Ecofriendly UV Spectrophotometric Methods for Quality Control of Telmisartan and Benidipine Formulations: Comparison of Whiteness and Greenness with HPLC Methods.

Authors:  Muhammad Shahzad Chohan; Mahesh Attimarad; Katharigatta Narayanaswamy Venugopala; Anroop Balachandran Nair; Nagaraja Sreeharsha; Efren Ii Plaza Molina; Ramling Bhagavantrao Kotnal; Sheeba Shafi; Marysheela David; Pottathil Shinu; Abdulrahman Ibrahim Altaysan; Abdulmalek Ahmed Balgoname
Journal:  Int J Environ Res Public Health       Date:  2022-06-14       Impact factor: 4.614

3.  Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers.

Authors:  Minkyung Oh; Sung-Eun Park; Jong-Lyul Ghim; Young-Kyung Choi; Eon-Jeong Shim; Jae-Gook Shin; Eun-Young Kim
Journal:  Drug Des Devel Ther       Date:  2017-12-11       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.